Published in J Neurosci Res on June 17, 2014
Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection. Stroke (2015) 0.77
Pericytes in Brain Injury and Repair After Ischemic Stroke. Transl Stroke Res (2016) 0.75
Design and evaluation of EphrinA1 mutants with cerebral protective effect. Sci Rep (2017) 0.75
Ischaemic concentrations of lactate increase TREK1 channel activity by interacting with a single histidine residue in the carboxy terminal domain. J Physiol (2015) 0.75
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med (2008) 28.42
Pericytes regulate the blood-brain barrier. Nature (2010) 6.62
Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature (2010) 5.47
Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron (2010) 5.20
Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke (1997) 3.94
Pericyte physiology. FASEB J (1993) 2.88
Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med (2009) 2.76
Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther (1994) 2.61
An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci (1997) 2.03
Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost (1981) 1.98
Blood-brain barrier biology and methodology. J Neurovirol (1999) 1.80
The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab (2004) 1.80
Plasminogen activator release at the neuronal growth cone. Science (1981) 1.63
Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front Neuroenergetics (2010) 1.59
NMDA receptor activation increases free radical production through nitric oxide and NOX2. J Neurosci (2009) 1.54
Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron (2006) 1.54
Angiogenic recruitment of pericytes from bone marrow after stroke. J Cereb Blood Flow Metab (2006) 1.36
Key role of tissue plasminogen activator in neurovascular coupling. Proc Natl Acad Sci U S A (2008) 1.30
Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse. PLoS One (2010) 1.28
Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J Cereb Blood Flow Metab (2009) 1.26
Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke (1988) 1.23
Brain microvascular pericytes in health and disease. Acta Neuropathol (2011) 1.20
Brain endothelial hemostasis regulation by pericytes. J Cereb Blood Flow Metab (2006) 1.18
Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants. J Biol Chem (1990) 1.16
Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J Neurosci (2003) 1.11
Cerebral ischemia and angiogenesis. Curr Neurovasc Res (2006) 1.09
Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1. J Biol Chem (2008) 1.09
Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Thromb Haemost (2004) 1.04
Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol Res (2004) 0.98
PDGF receptor β signaling in pericytes following ischemic brain injury. Curr Neurovasc Res (2012) 0.92
Morphology and molecular properties of cellular components of normal cerebral vessels. Methods Mol Med (2003) 0.92
Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage. Curr Neurovasc Res (2010) 0.90
The effect of moderate hypothermia in acute ischemic stroke on pericyte migration: an ultrastructural study. Cryobiology (2007) 0.88
Tissue plasminogen activator and glial function. Glia (2005) 0.88
Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (1999) 0.88
Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem Res (2011) 0.86
Implantation of a new porous gelatin-siloxane hybrid into a brain lesion as a potential scaffold for tissue regeneration. J Cereb Blood Flow Metab (2006) 0.84
Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat. Brain Res (2010) 0.84
Protective effect of ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol Res (2000) 0.83
Amelioration of brain edema by topical application of glial cell line-derived neurotrophic factor in reperfused rat brain. Neurosci Lett (1997) 0.81
Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain. Brain Res (2011) 0.80
Neurotrophin production in brain pericytes during hypoxia: a role of pericytes for neuroprotection. Microvasc Res (2012) 0.79
Differential expression of heat shock protein 70 gene between the cortex and caudate after transient focal cerebral ischaemia in rats. Neurol Res (1992) 0.79
Immunohistochemical localization of tissue plasminogen activator in vascular endothelium of stroke-prone regions of the rat brain. Neurosurgery (1998) 0.78
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A (2006) 10.09
Retracted Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. Cell (2011) 5.09
Mutations of optineurin in amyotrophic lateral sclerosis. Nature (2010) 4.54
Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet (2006) 3.87
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41
MicroRNA control of muscle development and disease. Curr Opin Cell Biol (2009) 3.04
MicroRNAs flex their muscles. Trends Genet (2008) 2.94
Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci (2006) 2.79
Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature (2012) 2.64
RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet (2009) 2.45
Prospective 10-year surveillance of human prion diseases in Japan. Brain (2010) 2.41
Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am J Hum Genet (2011) 2.19
Evidence for mutation showers. Proc Natl Acad Sci U S A (2007) 2.00
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun (2013) 2.00
Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci (2004) 1.92
Research on bell-shaped vibratory angular rate gyro's character of resonator. Sensors (Basel) (2013) 1.66
Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts. Int J Radiat Oncol Biol Phys (2008) 1.63
Scene-selective cortical regions in human and nonhuman primates. J Neurosci (2011) 1.62
Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog. J Nucl Med (2002) 1.62
Beta-catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells (2007) 1.53
Bis(benzyl-trimethyl-ammonium) tetra-bromidocuprate(II). Acta Crystallogr Sect E Struct Rep Online (2011) 1.52
Clinical features of SCA36: a novel spinocerebellar ataxia with motor neuron involvement (Asidan). Neurology (2012) 1.51
Des-gamma-carboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2013) 1.49
MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res (2011) 1.48
The value of patient-matched instrumentation in total knee arthroplasty. J Arthroplasty (2011) 1.47
HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol (2013) 1.47
An electrical impedance spectroscopy system for breast cancer detection. Conf Proc IEEE Eng Med Biol Soc (2007) 1.46
OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol (2012) 1.43
Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res (2007) 1.43
Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. Int J Radiat Oncol Biol Phys (2007) 1.39
MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Brain Res (2009) 1.37
H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health (2012) 1.36
Anisometropia in Hispanic and african american infants and young children the multi-ethnic pediatric eye disease study. Ophthalmology (2009) 1.35
Quantum dot-based local field imaging reveals plasmon-based interferometric logic in silver nanowire networks. Nano Lett (2010) 1.34
Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem (2005) 1.34
Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc Natl Acad Sci U S A (2012) 1.33
A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. Cancer Cell (2012) 1.32
MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS One (2012) 1.31
Regulation of survivin by PI3K/Akt/p70S6K1 pathway. Biochem Biophys Res Commun (2010) 1.30
MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. J Cancer Res Clin Oncol (2011) 1.27
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res (2005) 1.27
Increased incidence of transient left ventricular apical ballooning (so-called 'Takotsubo' cardiomyopathy) after the mid-Niigata Prefecture earthquake. Circ J (2006) 1.26
Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J Cereb Blood Flow Metab (2009) 1.26
Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. J Neurol Sci (2005) 1.23
MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci (2010) 1.23
miR-133a regulates adipocyte browning in vivo. PLoS Genet (2013) 1.22
Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. Nat Commun (2012) 1.22
Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant (2010) 1.21
Bis(benzyl-trimethyl-ammonium) dichromate(VI). Acta Crystallogr Sect E Struct Rep Online (2011) 1.21
Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab (2010) 1.19
Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol Rep (2010) 1.19
Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer (2014) 1.18
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem (2003) 1.14
Affinity purification of microRNA-133a with the cardiac transcription factor, Hand2. Proc Natl Acad Sci U S A (2010) 1.14
Nonparaneoplastic limbic encephalitis with relapsing polychondritis. J Neurol Sci (2004) 1.14
Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am J Hum Genet (2003) 1.13
Regulatory long non-coding RNA and its functions. J Physiol Biochem (2012) 1.13
Pael-R is accumulated in Lewy bodies of Parkinson's disease. Ann Neurol (2004) 1.12
Temporal profile of stem cell division, migration, and differentiation from subventricular zone to olfactory bulb after transient forebrain ischemia in gerbils. J Cereb Blood Flow Metab (2003) 1.12
IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J Immunol (2014) 1.11
Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol (2004) 1.11
High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway. J Bone Miner Res (2011) 1.10
Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation (2004) 1.09
Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas. Eur J Cancer (2013) 1.09
MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin Med J (Engl) (2011) 1.09
Cerebral ischemia and angiogenesis. Curr Neurovasc Res (2006) 1.09
Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J Cell Biol (2012) 1.08
Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure. J Hum Genet (2013) 1.08
Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res (2007) 1.07
A review of photocatalysis using self-organized TiO2 nanotubes and other ordered oxide nanostructures. Small (2012) 1.06
Regulation of let-7 and its target oncogenes (Review). Oncol Lett (2012) 1.06
Epigenetic regulation of neural cell differentiation plasticity in the adult mammalian brain. Proc Natl Acad Sci U S A (2008) 1.06
MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. RNA (2013) 1.06
Three steps of neural stem cells development in gerbil dentate gyrus after transient ischemia. J Cereb Blood Flow Metab (2002) 1.06
New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol (2011) 1.06
Urinary retention secondary to Listeria meningitis. Intern Med (2008) 1.06
High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro Oncol (2011) 1.06
Severe myopathy in mice lacking the MEF2/SRF-dependent gene leiomodin-3. J Clin Invest (2015) 1.06
Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am J Pathol (2005) 1.05
Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro Oncol (2013) 1.05
MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells. J Neurooncol (2014) 1.05
Expression of netrin-1 and its receptors DCC and neogenin in rat brain after ischemia. Brain Res (2007) 1.04
Enhanced neurogenesis in the ischemic striatum following EGF-induced expansion of transit-amplifying cells in the subventricular zone. Neurosci Lett (2006) 1.04
Clinical significance of Hiwi gene expression in gliomas. Brain Res (2010) 1.04
Distribution and regulation of protein expression of the free fatty acid receptor GPR120. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.04
FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation. Cell Res (2013) 1.03
Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab (2012) 1.03
Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.03
Serial diffusion-weighted MRI and SPECT findings in a Creutzfeldt-Jakob disease patient with V180I mutation. J Neurol Sci (2010) 1.02
Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation. Pharmacol Res (2006) 1.02
MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth. CNS Neurosci Ther (2012) 1.01
Drastic symmetry breaking in supramolecular organization of enantiomerically unbalanced monolayers at surfaces. Nat Chem (2009) 1.01
MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma. BMC Cancer (2014) 1.01
In vivo imaging of autophagy in a mouse stroke model. Autophagy (2010) 1.00